Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ranitidine administration in Henoch-Schönlein vasculitis

N Narin1, A Akçoral, M I Aslin

  • 1Dr Behçet Uz Children's Hospital, Izmir, Turkey.

Acta Paediatrica Japonica : Overseas Edition
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers.

Cardiology in the young·2023
Same author

Closure of transcatheter ventricular septal defect using LifetechTM Konar-MF Occluder in children weighing less than 10 kilograms: mid-term results, a tertiary single center experience.

European review for medical and pharmacological sciences·2023
Same author

Early onset marfan syndrome: Atypical clinical presentation of two cases.

Balkan journal of medical genetics : BJMG·2016
Same author

Evaluation of Cardiovascular Changes in Children with BAVs.

Pediatric cardiology·2015
Same author

Cardiovascular changes in children with coarctation of the aorta treated by endovascular stenting.

Journal of human hypertension·2013
Same author

Atypical presentation and a novel mutation in ALMS1: implications for clinical and molecular diagnostic strategies for Alström syndrome.

Clinical genetics·2012

This study found ranitidine significantly reduced abdominal pain and gastrointestinal bleeding in children with Henoch Schoenlein vasculitis (HSV). Ranitidine is a safe and effective treatment option for HSV patients experiencing GI symptoms.

Area of Science:

  • Pediatric Gastroenterology
  • Rheumatology
  • Clinical Pharmacology

Background:

  • Henoch Schoenlein vasculitis (HSV) is a common childhood vasculitis.
  • Gastrointestinal (GI) bleeding and abdominal pain are significant complications of HSV.
  • Limited treatment options exist for managing GI symptoms in HSV.

Purpose of the Study:

  • To evaluate the efficacy of ranitidine in treating GI bleeding and abdominal pain in pediatric patients with Henoch Schoenlein vasculitis.
  • To compare ranitidine's effectiveness against a placebo in managing HSV-related GI symptoms.

Main Methods:

  • A randomized, placebo-controlled trial involving 12 pediatric patients diagnosed with Henoch Schoenlein vasculitis.
  • Patients aged 6-14 years were divided into two groups, receiving either ranitidine or a placebo.

Related Experiment Videos

  • Outcomes measured included the duration and severity of abdominal pain and GI bleeding.

    • Main Results:

    • Ranitidine administration led to a statistically significant decrease in the duration and severity of abdominal pain and GI bleeding compared to placebo (P < 0.05).
    • No adverse side effects were reported in the ranitidine group.
    • The study demonstrated a clear benefit of ranitidine in alleviating GI manifestations of HSV.

    Conclusions:

    • Ranitidine is an effective and safe therapeutic option for managing gastrointestinal symptoms in children with Henoch Schoenlein vasculitis.
    • The findings support the use of ranitidine as an adjunct treatment for pediatric HSV patients presenting with GI bleeding and pain.